Cargando…
A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma
Zinc-finger protein 304 (ZNF304) plays a critical role in silencing genes through transcription, regulating cell survival, proliferation, apoptosis, and differentiation during development. However, the roles of transcription factor ZNF304 and its clinical significance in clear cell renal carcinoma (...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529286/ https://www.ncbi.nlm.nih.gov/pubmed/34692488 http://dx.doi.org/10.3389/fonc.2021.710525 |
_version_ | 1784586438380093440 |
---|---|
author | Ren, Li-Xin Zeng, Bo-Wen Zhu, Meng Zhao, An-Ning Shi, Bei Zhang, Hong Wang, Dan-Dan Gu, Jun-Fei Yang, Zhan |
author_facet | Ren, Li-Xin Zeng, Bo-Wen Zhu, Meng Zhao, An-Ning Shi, Bei Zhang, Hong Wang, Dan-Dan Gu, Jun-Fei Yang, Zhan |
author_sort | Ren, Li-Xin |
collection | PubMed |
description | Zinc-finger protein 304 (ZNF304) plays a critical role in silencing genes through transcription, regulating cell survival, proliferation, apoptosis, and differentiation during development. However, the roles of transcription factor ZNF304 and its clinical significance in clear cell renal carcinoma (ccRCC) remain unclear. In this study, we found that the expression of ZNF304 was downregulated in ccRCC tissues. Lower levels of ZNF304 were correlated with poor survival. Downregulation of ZNF304 promoted ccRCC cell growth in vitro, whereas overexpression of ZNF304 inhibited growth. Our results indicated that miR-183-5p/FOXO4 mediated ZNF304 regulation of cell growth. Interestingly, we revealed that ZNF304 promoted FOXO4 expression in ccRCC cells. Mechanistically, ZNF304 binds to miR-183 promoter and inhibits miR-183-5p transcription. Furthermore, the expression of miR-183-5p wes increased in ccRCC tissues, and the upregulation of miR-183-5p was related to the poor prognosis of ccRCC patients. miR-183-5p upregulation repressed the expression of FOXO4 and promoted ccRCC progression. These results demonstrated that ZNF304/miR-183-5p/FOXO4 axis played essential role in promoting ccRCC progression, which suggests that disruption of this axis may be a potential therapeutic target in ccRCC. |
format | Online Article Text |
id | pubmed-8529286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85292862021-10-22 A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma Ren, Li-Xin Zeng, Bo-Wen Zhu, Meng Zhao, An-Ning Shi, Bei Zhang, Hong Wang, Dan-Dan Gu, Jun-Fei Yang, Zhan Front Oncol Oncology Zinc-finger protein 304 (ZNF304) plays a critical role in silencing genes through transcription, regulating cell survival, proliferation, apoptosis, and differentiation during development. However, the roles of transcription factor ZNF304 and its clinical significance in clear cell renal carcinoma (ccRCC) remain unclear. In this study, we found that the expression of ZNF304 was downregulated in ccRCC tissues. Lower levels of ZNF304 were correlated with poor survival. Downregulation of ZNF304 promoted ccRCC cell growth in vitro, whereas overexpression of ZNF304 inhibited growth. Our results indicated that miR-183-5p/FOXO4 mediated ZNF304 regulation of cell growth. Interestingly, we revealed that ZNF304 promoted FOXO4 expression in ccRCC cells. Mechanistically, ZNF304 binds to miR-183 promoter and inhibits miR-183-5p transcription. Furthermore, the expression of miR-183-5p wes increased in ccRCC tissues, and the upregulation of miR-183-5p was related to the poor prognosis of ccRCC patients. miR-183-5p upregulation repressed the expression of FOXO4 and promoted ccRCC progression. These results demonstrated that ZNF304/miR-183-5p/FOXO4 axis played essential role in promoting ccRCC progression, which suggests that disruption of this axis may be a potential therapeutic target in ccRCC. Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529286/ /pubmed/34692488 http://dx.doi.org/10.3389/fonc.2021.710525 Text en Copyright © 2021 Ren, Zeng, Zhu, Zhao, Shi, Zhang, Wang, Gu and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ren, Li-Xin Zeng, Bo-Wen Zhu, Meng Zhao, An-Ning Shi, Bei Zhang, Hong Wang, Dan-Dan Gu, Jun-Fei Yang, Zhan A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma |
title | A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma |
title_full | A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma |
title_fullStr | A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma |
title_full_unstemmed | A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma |
title_short | A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma |
title_sort | novel znf304/mir-183-5p/foxo4 pathway regulates cell proliferation in clear cell renal carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529286/ https://www.ncbi.nlm.nih.gov/pubmed/34692488 http://dx.doi.org/10.3389/fonc.2021.710525 |
work_keys_str_mv | AT renlixin anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zengbowen anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zhumeng anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zhaoanning anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT shibei anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zhanghong anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT wangdandan anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT gujunfei anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT yangzhan anovelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT renlixin novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zengbowen novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zhumeng novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zhaoanning novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT shibei novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT zhanghong novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT wangdandan novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT gujunfei novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma AT yangzhan novelznf304mir1835pfoxo4pathwayregulatescellproliferationinclearcellrenalcarcinoma |